MedPath
FDA Approval

Argatroban

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 20, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Argatroban(250 mg in 2.5 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Hikma Pharmaceuticals USA Inc.

001230762

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Argatroban

Product Details

NDC Product Code
0143-9288
Application Number
NDA203049
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
October 20, 2020
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
Code: IY90U61Z3SClass: ACTIMQuantity: 250 mg in 2.5 mL
© Copyright 2025. All Rights Reserved by MedPath